Pavmed Inc (PAVM) Stock Price, Quote & News - Mboum

Company Profile

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precance...

Industry: Medical Devices

Sector: Healthcare

Phone: 917 813 1828

Website: www.pavmed.com

Address:

360 Madison Avenue, 25th Floor, New York, United States

vvvvvvrebel89130 Feb. 3 at 12:24 AM

$PAVM any ideas on the spike?

0 · Reply

Moneyfrog Feb. 2 at 8:47 PM

$IOTR $ELPW $PAVM IOTR be early ⏰️🔥

0 · Reply

gravillx Feb. 2 at 8:46 PM

$PAVM Low float as fuck, thin supply, you sneeze size and this thing jumps. Volume 2.8M vs 2.1M avg, price holding 0.86+, power hour ticking. That’s how $1 sneaks up fast. 🔥📈

0 · Reply

FlashMcGash Feb. 2 at 8:40 PM

$PAVM looks like its setting up for a big move.

1 · Reply

Moneyfrog Feb. 2 at 8:22 PM

$IOTR 3.8$BREAK this could go like $PAVM Easy with 600k float

0 · Reply

vvvvvvrebel89130 Feb. 2 at 8:22 PM

$PAVM halt

1 · Reply

Was_Up Feb. 2 at 8:22 PM

$PAVM wen volume

0 · Reply

vvvvvvrebel89130 Feb. 2 at 8:20 PM

0 · Reply

chuckjackson Feb. 2 at 8:19 PM

$PAVM and lucd inching up. Traders must be anticipating release of draft coverage this week

0 · Reply

Moneyfrog Feb. 2 at 8:01 PM

$IOTR $ELPW $PAVM $FUSE IOTR about to leave the station 🔥🔥👀👀

0 · Reply

Latest News on PAVM

Should you chase the rally in PAVmed stock after it quadrupled on Wednesday?

Jan 21, 2026, 3:40 PM EST - 12 days ago

Should you chase the rally in PAVmed stock after it quadrupled on Wednesday?

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®

Jan 21, 2026, 8:00 AM EST - 13 days ago

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®

PAVmed Announces Reverse Stock Split

Dec 30, 2025, 9:01 AM EST - 4 weeks ago

PAVmed Announces Reverse Stock Split

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection

Dec 9, 2025, 8:01 AM EST - 2 months ago

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection

PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript

Dec 5, 2025, 11:08 AM EST - 2 months ago

PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree

Nov 20, 2025, 8:15 AM EST - 2 months ago

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree

PAVmed Inc. (PAVM) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 11:31 AM EST - 2 months ago

PAVmed Inc. (PAVM) Q3 2025 Earnings Call Transcript

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Nov 13, 2025, 8:15 AM EST - 2 months ago

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 8:00 AM EST - 2 months ago

PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 8:00 AM EST - 2 months ago

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results

PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025

Oct 30, 2025, 8:01 AM EDT - 3 months ago

PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025

Oct 29, 2025, 8:01 AM EDT - 3 months ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025

Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit

Oct 15, 2025, 8:01 AM EDT - 3 months ago

Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit

PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement

Oct 7, 2025, 8:01 AM EDT - 4 months ago

PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement

Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs

Sep 16, 2025, 8:01 AM EDT - 5 months ago

Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs

Lucid Diagnostics Announces Closing of Public Offering of Common Stock

Sep 11, 2025, 9:17 AM EDT - 5 months ago

Lucid Diagnostics Announces Closing of Public Offering of Common Stock

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

Sep 10, 2025, 8:00 AM EDT - 5 months ago

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

Lucid Diagnostics Announces Proposed Public Offering of Common Stock

Sep 9, 2025, 4:01 PM EDT - 5 months ago

Lucid Diagnostics Announces Proposed Public Offering of Common Stock

Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025

Sep 5, 2025, 9:16 AM EDT - 5 months ago

Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025

Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025

Aug 27, 2025, 8:00 AM EDT - 5 months ago

Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025

PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology

Aug 26, 2025, 8:01 AM EDT - 5 months ago

PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology

PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results

Aug 14, 2025, 8:00 AM EDT - 6 months ago

PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 8:00 AM EDT - 6 months ago

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results

Lucid Diagnostics to Participate in Upcoming Investor Conferences

Aug 5, 2025, 8:00 AM EDT - 6 months ago

Lucid Diagnostics to Participate in Upcoming Investor Conferences

PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025

Jul 31, 2025, 8:01 AM EDT - 6 months ago

PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025

Jul 30, 2025, 8:01 AM EDT - 6 months ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025

PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Jul 30, 2025, 8:00 AM EDT - 6 months ago

PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test

Jul 16, 2025, 7:31 AM EDT - 7 months ago

MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test

PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing

Jun 24, 2025, 8:01 AM EDT - 8 months ago

PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test

Jun 18, 2025, 12:02 PM EDT - 8 months ago

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test

PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Jun 3, 2025, 8:31 AM EDT - 8 months ago

PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes

May 27, 2025, 7:31 AM EDT - 9 months ago

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes

PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript

May 15, 2025, 1:58 PM EDT - 9 months ago

PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript

PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results

May 15, 2025, 8:01 AM EDT - 9 months ago

PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results

Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results

May 14, 2025, 8:01 AM EDT - 9 months ago

Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

May 1, 2025, 8:31 AM EDT - 9 months ago

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025

Apr 30, 2025, 8:31 AM EDT - 9 months ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025

NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD

Apr 24, 2025, 8:01 AM EDT - 10 months ago

NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD

Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

Apr 3, 2025, 9:00 AM EDT - 10 months ago

Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology

Mar 27, 2025, 8:01 AM EDT - 11 months ago

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology

PAVmed Inc. (PAVM) Q4 2024 Earnings Call Transcript

Mar 25, 2025, 11:08 AM EDT - 11 months ago

PAVmed Inc. (PAVM) Q4 2024 Earnings Call Transcript

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 25, 2025, 8:01 AM EDT - 11 months ago

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 24, 2025, 8:01 AM EDT - 11 months ago

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening

Mar 20, 2025, 8:31 AM EDT - 11 months ago

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

Mar 18, 2025, 8:31 AM EDT - 11 months ago

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test

Mar 13, 2025, 7:36 AM EDT - 11 months ago

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025

Mar 10, 2025, 9:01 AM EDT - 11 months ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering

Mar 5, 2025, 4:45 PM EST - 11 months ago

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering

Mar 4, 2025, 8:25 AM EST - 1 year ago

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering

Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD

Feb 27, 2025, 8:31 AM EST - 1 year ago

Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD

vvvvvvrebel89130 Feb. 3 at 12:24 AM

$PAVM any ideas on the spike?

0 · Reply

Moneyfrog Feb. 2 at 8:47 PM

$IOTR $ELPW $PAVM IOTR be early ⏰️🔥

0 · Reply

gravillx Feb. 2 at 8:46 PM

$PAVM Low float as fuck, thin supply, you sneeze size and this thing jumps. Volume 2.8M vs 2.1M avg, price holding 0.86+, power hour ticking. That’s how $1 sneaks up fast. 🔥📈

0 · Reply

FlashMcGash Feb. 2 at 8:40 PM

$PAVM looks like its setting up for a big move.

1 · Reply

Moneyfrog Feb. 2 at 8:22 PM

$IOTR 3.8$BREAK this could go like $PAVM Easy with 600k float

0 · Reply

vvvvvvrebel89130 Feb. 2 at 8:22 PM

$PAVM halt

1 · Reply

Was_Up Feb. 2 at 8:22 PM

$PAVM wen volume

0 · Reply

vvvvvvrebel89130 Feb. 2 at 8:20 PM

0 · Reply

chuckjackson Feb. 2 at 8:19 PM

$PAVM and lucd inching up. Traders must be anticipating release of draft coverage this week

0 · Reply

Moneyfrog Feb. 2 at 8:01 PM

$IOTR $ELPW $PAVM $FUSE IOTR about to leave the station 🔥🔥👀👀

0 · Reply

Moneyfrog Feb. 2 at 7:54 PM

$IOTR $ELPW $PAVM IOTR ABOUT TO LEAVE THE STATION ⏰️🔥

0 · Reply

Investor_Scale Feb. 2 at 7:53 PM

$PAVM halted ?!

0 · Reply

Moneyfrog Feb. 2 at 7:50 PM

$IOTR above 3.5 opens it could easy pull a $PAVM $PBM move Tiny float known runner

0 · Reply

Moneyfrog Feb. 2 at 7:46 PM

$IOTR 600k float 700% CTB could get a huge move soon Reminds me of $ELPW $PAVM Be early

2 · Reply

vvvvvvrebel89130 Feb. 2 at 7:45 PM

$PAVM fake news

0 · Reply

Nesabbah Feb. 2 at 6:41 PM

$PAVM the FDA submission is due any date. Once the need is out. It could spike to $30 in few mins.

3 · Reply

MagiCarpX Feb. 2 at 4:46 PM

$PAVM I’ll be very curious to see if lunch time brings a big flush or the run continues

0 · Reply

Spacerobot Feb. 2 at 4:34 PM

$PAVM may crunch up again prob. maybe even past the previous point.

3 · Reply

Rachs88 Feb. 2 at 4:31 PM

$PAVM manipulation at its finest by the MMs. Dropped it fully so everyone exits and not letting it run lol

0 · Reply

MagiCarpX Feb. 2 at 4:21 PM

$PAVM if it can make past 9 it may run

0 · Reply

Alexsands Feb. 2 at 4:17 PM

$PAVM filled today's gap up. Now let's go!

0 · Reply

Investor_Scale Feb. 2 at 4:14 PM

$PAVM now slowly up to 12…. No spike

1 · Reply